11/14/2024 2:22 PM | ARMISTICE CAPITAL, LLC (Filed by) Avenue Therapeutics (Subject)
| Form SC 13G | |
11/07/2024 6:12 PM | Avenue Therapeutics (Issuer) KRANZLER JAY D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 3:18 PM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2024 3:53 PM | Avenue Therapeutics (Issuer) Charles Faith L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:53 PM | Avenue Therapeutics (Issuer) Jin David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:54 PM | Avenue Therapeutics (Issuer) KRANZLER JAY D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:55 PM | Avenue Therapeutics (Issuer) MacLean Alexandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/25/2024 3:55 PM | Avenue Therapeutics (Issuer) Oltmans Curtis Gale (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:57 PM | Avenue Therapeutics (Issuer) Herskowitz Neil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2024 3:59 PM | Avenue Therapeutics (Issuer) ROSENWALD LINDSAY A MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 3:16 PM | Avenue Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/26/2024 3:52 PM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2024 7:30 AM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 8:01 AM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/12/2024 11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
03/29/2024 1:41 PM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 6:15 AM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 3:31 PM | Avenue Therapeutics (Filer)
| Form PRE 14C | |
02/23/2024 3:17 PM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 11:15 PM | Avenue Therapeutics (Filer)
| Form EFFECT | |
01/29/2024 7:00 AM | Avenue Therapeutics (Filer)
| Form DEF 14C | |
01/17/2024 4:05 PM | Avenue Therapeutics (Filer)
| Form PRE 14C | |
01/12/2024 5:01 AM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 4:28 PM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 2:45 PM | Avenue Therapeutics (Subject) SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/28/2023 3:01 PM | Avenue Therapeutics (Issuer) Davidow Robert L (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/24/2023 12:19 PM | Avenue Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |